Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis
| Autor: | Ćulafić Milica, Vezmar-Kovačević Sandra, Dopsaj Violeta, Oluić Branislav, Bidžić Nemanja, Miljković Branislava, Ćulafić Đorđe |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Journal of Medical Biochemistry, Vol 39, Iss 3, Pp 290-298 (2020) |
| Druh dokumentu: | article |
| ISSN: | 1452-8258 1452-8266 |
| Popis: | Background: The progression of the nonalcoholic fatty liver disease to nonalcoholic steatohepatitis (NASH) is multifactorial, and there is still a lack of approved medications for its treatment. The study aimed to evaluate the impact of combined treatment with Pentoxifylline and Metformin on biochemical parameters in patients with Nash. Setting: Outpatient hepatology clinic. Methods: A prospective trial was conducted. The first cohort included patients with biopsy-proven Nash, while the second cohort consisted of patients with biopsy-confirmed NAFLD. Blood tests were checked at baseline and every three months. Pentoxifylline at a dosage of 400 mg t.i.d. and Metformin at the dosage of 500 mg t.i.d. were introduced for six months in Nash group. The impact of the treatment was assessed based on biochemical results after combined treatment with low-cost medications. Results: All 33 Nash patients completed 24 weeks of treatment. We observed significant improvement (p |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|